Skip to main content
Back to SFC Capital

SFC Capital's Pharmaceutical Portfolio

Browse 3 Pharmaceutical companies funded by SFC Capital. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
3
Total Funding in Pharmaceutical
$3.4M

Pharmaceutical Portfolio Companies (3)

Export
BiotechnologyPharmaceuticalTherapeutics

Cellestial Health is a preclinical biopharmaceutical company.

Cambridge, United States
September 2025
$74K
Grant

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedical DeviceNeurosciencePharmaceuticalSoftware

PREMAZ is a health tech company providing a digital cognitive assessment tool for early detection and monitoring of subtle memory change.

London, United Kingdom
May 2026
$736K
Pre-Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyCommercialHealth CareImpact InvestingMedical DevicePharmaceuticalProduct ResearchWellness

Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines and therapeutics into fridge free thermostable products.

Bath, United Kingdom
February 2025
$2.6M
Grant

Founder Contacts

30,000+ verified contacts

Explore SFC Capital's Full Portfolio

View all companies funded by SFC Capital across every industry and funding stage.

View Full SFC Capital Portfolio